tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
US Market
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Balance Sheet

26 Followers

Shanghai Fosun Pharmaceutical (Group) Co Balance Sheet

Shanghai Fosun Pharmaceutical (Group) Co's total assets for Q4 2025 were ¥120.07B, an increase of 1.04% from the previous quarter. SFOSF total liabilities were ¥58.24B for the fiscal quarter, a -0.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
¥ 120.07B¥ 117.46B¥ 113.47B¥ 107.16B¥ 93.29B
Total Liabilities
¥ 58.24B¥ 57.53B¥ 56.85B¥ 53.05B¥ 44.92B
Total Equity Gross Minority
¥ 61.83B¥ 59.93B¥ 56.62B¥ 54.11B¥ 48.38B
Other Metrics
Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets